• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术治疗戈谢病难治性腹水

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease.

作者信息

Adhyaru Kunal, Menezes Sherna, Mistry Pramod K, Nagral Aabha

机构信息

Department of Gastroenterology and Hepatology, Jaslok Hospital and Research Centre, Mumbai, IND.

Department of Internal Medicine, Yale University, New Haven, USA.

出版信息

Cureus. 2022 Apr 8;14(4):e23941. doi: 10.7759/cureus.23941. eCollection 2022 Apr.

DOI:10.7759/cureus.23941
PMID:35535294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9079779/
Abstract

Gaucher disease is rare, inherited lysosomal storage disorder that leads to the excessive accumulation of certain lipids, especially within the bone marrow, liver, and spleen. We present a case of a 30-year-old man with Gaucher disease who underwent a splenectomy at the age of eight for severe cytopenia. His subsequent history was notable for recurrent avascular osteonecrosis and his liver disease progressed to portal hypertension, variceal bleeding, and refractory ascites. Upon evaluation of his candidacy for liver transplantation, he was sarcopenic, with tense, high serum-ascites albumin gradient (SAAG) ascites and florid venous collaterals on his anterior abdominal wall. His hepatic venous pressure gradient (HVPG) was 22 mmHg. He underwent a transjugular intrahepatic portosystemic shunt (TIPS) procedure, following which his HVPG was reduced to 2 mmHg and striking reversal of ascites as well as improvement of his nutritional state. TIPS was not complicated by hepatic encephalopathy. The successful outcome of TIPS in Gaucher disease with advanced hepatic disease underscores its utility as a bridge to liver transplantation with continuing enzyme replacement therapy.

摘要

戈谢病是一种罕见的遗传性溶酶体贮积症,会导致某些脂质过度蓄积,尤其是在骨髓、肝脏和脾脏中。我们报告一例30岁戈谢病男性患者,其8岁时因严重血细胞减少接受了脾切除术。他随后的病史以复发性无菌性骨坏死为显著特征,其肝脏疾病进展为门静脉高压、静脉曲张出血和难治性腹水。在评估其肝移植候选资格时,他存在肌肉减少症,有张力性、高血清腹水白蛋白梯度(SAAG)腹水,且前腹壁有明显的静脉侧支循环。他的肝静脉压力梯度(HVPG)为22 mmHg。他接受了经颈静脉肝内门体分流术(TIPS),术后其HVPG降至2 mmHg,腹水显著消退,营养状况改善。TIPS未并发肝性脑病。TIPS在晚期肝病戈谢病患者中取得成功,凸显了其作为继续酶替代治疗的肝移植桥梁的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a107/9079779/540ac5a861df/cureus-0014-00000023941-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a107/9079779/0eb1c4588557/cureus-0014-00000023941-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a107/9079779/540ac5a861df/cureus-0014-00000023941-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a107/9079779/0eb1c4588557/cureus-0014-00000023941-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a107/9079779/540ac5a861df/cureus-0014-00000023941-i02.jpg

相似文献

1
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease.经颈静脉肝内门体分流术治疗戈谢病难治性腹水
Cureus. 2022 Apr 8;14(4):e23941. doi: 10.7759/cureus.23941. eCollection 2022 Apr.
2
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.使用新型VIATORR®可控扩张支架进行控制性扩张不足可提高经颈静脉肝内门体分流术植入后的生存率。
JHEP Rep. 2021 Mar 3;3(3):100264. doi: 10.1016/j.jhepr.2021.100264. eCollection 2021 Jun.
3
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水:经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
4
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.经颈静脉肝内门体分流术治疗肝硬化患者:适应证和 2020 年经颈静脉肝内门体分流术相关并发症。
United European Gastroenterol J. 2021 Mar;9(2):203-208. doi: 10.1177/2050640620952637. Epub 2021 Feb 23.
5
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
6
[Preliminary application of transjugular intrahepatic portosystemic shunt in individualized treatment of patients with cirrhotic portal hypertension complicated with refractory ascites and variceal hemorrhage].经颈静脉肝内门体分流术在肝硬化门静脉高压症合并顽固性腹水及曲张静脉出血患者个体化治疗中的初步应用
Zhonghua Yi Xue Za Zhi. 2019 Dec 17;99(47):3737-3740. doi: 10.3760/cma.j.issn.0376-2491.2019.47.012.
7
Portal decompression by transjugular intrahepatic portosystemic shunt and changes in serum-ascites albumin gradient.经颈静脉肝内门体分流术进行门脉减压及血清腹水白蛋白梯度的变化
J Clin Gastroenterol. 1998 Sep;27(2):149-51. doi: 10.1097/00004836-199809000-00010.
8
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.肝硬化患者经颈静脉肝内门体分流术:详尽的批判性更新。
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
9
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.经颈静脉肝内门体分流术(TIPS)在门静脉高压症治疗中的作用。
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500.
10
Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术置入后的发病率和死亡率。
Eur J Gastroenterol Hepatol. 2019 May;31(5):626-632. doi: 10.1097/MEG.0000000000001342.

本文引用的文献

1
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist.戈谢病的肝脏受累:肝病学家和胃肠病学家的实用综述。
Dig Liver Dis. 2020 Apr;52(4):368-373. doi: 10.1016/j.dld.2020.01.004. Epub 2020 Feb 11.
2
Lysosomal storage disease overview.溶酶体贮积症概述。
Ann Transl Med. 2018 Dec;6(24):476. doi: 10.21037/atm.2018.11.39.
3
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease.1 型戈谢病患者应用振动控制瞬时弹性成像技术评估肝脏纤维化的流行率和预测因子。
Mol Genet Metab. 2018 Sep;125(1-2):64-72. doi: 10.1016/j.ymgme.2018.08.004. Epub 2018 Aug 11.
4
Liver involvement in Gaucher disease - Review and clinical approach.戈谢病的肝脏受累——综述与临床处理方法
Blood Cells Mol Dis. 2018 Feb;68:66-73. doi: 10.1016/j.bcmd.2016.10.001. Epub 2016 Oct 19.
5
Gaucher disease.戈谢病
J Clin Exp Hepatol. 2014 Mar;4(1):37-50. doi: 10.1016/j.jceh.2014.02.005. Epub 2014 Apr 21.
6
Long-term outcomes of liver transplantation in type 1 Gaucher disease.1 型戈谢病肝移植的长期结局。
Am J Transplant. 2010 Aug;10(8):1934-9. doi: 10.1111/j.1600-6143.2010.03168.x.